NASDAQ:ACRX - AcelRx Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$4.15 -0.45 (-9.78 %)
(As of 09/25/2018 04:00 PM ET)
Previous Close$4.60
Today's Range$3.90 - $4.70
52-Week Range$1.55 - $5.75
Volume2.42 million shs
Average Volume597,775 shs
Market Capitalization$239.37 million
P/E Ratio-3.77
Dividend YieldN/A

Analyst Ratings

AcelRx Pharmaceuticals (NASDAQ:ACRX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for AcelRx Pharmaceuticals in the last 12 months. Their average twelve-month price target is $5.50, suggesting that the stock has a possible upside of 32.53%. The high price target for ACRX is $8.00 and the low price target for ACRX is $2.00. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.632.632.632.57
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.50$5.50$5.50$5.40
Price Target Upside: 32.53% upside86.44% upside34.15% upside200.00% upside

AcelRx Pharmaceuticals (NASDAQ:ACRX) Consensus Price Target History

Price Target History for AcelRx Pharmaceuticals (NASDAQ:ACRX)

AcelRx Pharmaceuticals (NASDAQ:ACRX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/20/2018Cantor FitzgeraldReiterated RatingBuy$6.00LowView Rating Details
8/16/2018LADENBURG THALM/SH SHInitiated CoverageBuy$7.00HighView Rating Details
8/7/2018HC WainwrightReiterated RatingBuyLowView Rating Details
8/3/2018OppenheimerReiterated RatingHoldHighView Rating Details
10/13/2017Piper Jaffray CompaniesReiterated RatingHold$2.00N/AView Rating Details
10/13/2017Royal Bank of CanadaLower Price TargetOutperform ➝ Outperform$6.00 ➝ $5.00N/AView Rating Details
10/13/2017Jefferies Financial GroupDowngradeBuy ➝ HoldN/AView Rating Details
10/12/2017Roth CapitalSet Price TargetBuy$8.00N/AView Rating Details
8/9/2017Stifel NicolausUpgradeHold ➝ BuyHighView Rating Details
8/1/2017CowenReiterated RatingHoldHighView Rating Details
(Data available from 9/25/2016 forward)
This page was last updated on 9/25/2018 by Staff

Featured Article: Buyback

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel